Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, has announced that its Quality Control laboratory and the associated Quality system has been inspected for good-manufacturing-practice by the Dutch Health Care Inspectorate and has fully met the EU GMP standards.
http://www.medilexicon.com/medicalnews.php?newsid=263818
http://www.medilexicon.com/medicalnews.php?newsid=263818
No comments:
Post a Comment